{"name": "Anacor Pharmaceutical",
 "permalink": "anacor-pharmaceutical",
 "crunchbase_url": "http://www.crunchbase.com/company/anacor-pharmaceutical",
 "homepage_url": "http://www.anacor.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": 31,
 "founded_year": 2000,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@anacor.com",
 "phone_number": "(650) 543-7500",
 "description": "Biotherapeutics Developer",
 "created_at": "Fri Jun 19 06:26:09 UTC 2009",
 "updated_at": "Thu Jun 13 03:59:32 UTC 2013",
 "overview": "\u003Cp\u003EAnacor Pharmaceuticals is a biopharmaceutical company that engages in developing small-molecule therapeutics from its boron chemistry platform. It focuses on developing topical applications of its compounds to treat fungal, bacterial, and inflammatory diseases. \u003C/p\u003E\n\n\u003Cp\u003EThe company\u00e2\u20ac\u2122s primary product candidate, AN2690, is a novel topical antifungal for the treatment of toenail onychomycosis, a fungal infection of the nail and nail bed. It is also developing AN2728, an anti-inflammatory product candidate for the treatment of psoriasis; AN0128, a product candidate that has antibiotic and anti-inflammatory properties; and AN2718, which is in preclinical development for the topical treatment of vaginal candidiasis and tineapedis. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       50],
      "assets/images/resized/0004/9566/49566v1-max-150x150.png"],
     [[171,
       57],
      "assets/images/resized/0004/9566/49566v1-max-250x250.png"],
     [[171,
       57],
      "assets/images/resized/0004/9566/49566v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Senior VP and CFO",
    "person":
     {"first_name": "Geoffrey",
      "last_name": "Parker",
      "permalink": "geoffrey-parker",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$192M",
 "funding_rounds":
  [{"round_code": "e",
    "source_url": "http://www.bio-medicine.org/biology-technology-1/Anacor-Raises--2450-Million-in-Equity-Financing-9800-1/",
    "source_description": "Anacor Raises $50 Million in Equity Financing",
    "raised_amount": 50000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 1,
    "funded_day": 6,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "GSK Venture Fund",
         "permalink": "gsk-venture-fund",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Rho Capital Partners",
         "permalink": "rho-capital-ventures",
         "image":
          {"available_sizes":
            [[[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-150x150.jpg"],
             [[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-250x250.jpg"],
             [[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Venrock",
         "permalink": "venrock",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0001/6279/16279v1-max-150x150.jpg"],
             [[250,
               87],
              "assets/images/resized/0001/6279/16279v1-max-250x250.jpg"],
             [[351,
               123],
              "assets/images/resized/0001/6279/16279v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Care Capital",
         "permalink": "care-capital",
         "image":
          {"available_sizes":
            [[[110,
               80],
              "assets/images/resized/0004/9581/49581v1-max-150x150.jpg"],
             [[110,
               80],
              "assets/images/resized/0004/9581/49581v1-max-250x250.jpg"],
             [[110,
               80],
              "assets/images/resized/0004/9581/49581v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Aberdare Ventures",
         "permalink": "aberdare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               28],
              "assets/images/resized/0005/3038/53038v1-max-150x150.jpg"],
             [[250,
               47],
              "assets/images/resized/0005/3038/53038v1-max-250x250.jpg"],
             [[300,
               57],
              "assets/images/resized/0005/3038/53038v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "Schering",
         "permalink": "schering",
         "image":
          {"available_sizes":
            [[[150,
               56],
              "assets/images/resized/0004/9570/49570v2-max-150x150.jpg"],
             [[166,
               62],
              "assets/images/resized/0004/9570/49570v2-max-250x250.jpg"],
             [[166,
               62],
              "assets/images/resized/0004/9570/49570v2-max-450x450.jpg"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://deals.venturebeat.com/2007/02/05/anacor-anti-fungal-therapy-co-gets-50m-from-schering-plough/",
    "source_description": "Anacor, anti-fungal therapy co., gets $50M from Schering-Plough",
    "raised_amount": 50000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 2,
    "funded_day": 5,
    "investments":
     [{"company":
        {"name": "Schering",
         "permalink": "schering",
         "image":
          {"available_sizes":
            [[[150,
               56],
              "assets/images/resized/0004/9570/49570v2-max-150x150.jpg"],
             [[166,
               62],
              "assets/images/resized/0004/9570/49570v2-max-250x250.jpg"],
             [[166,
               62],
              "assets/images/resized/0004/9570/49570v2-max-450x450.jpg"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://anacor.com/press_release_2005-05-11a.php",
    "source_description": "ANACOR PHARMACEUTICALS RAISES $25 MILLION IN SERIES C FINANCING",
    "raised_amount": 25000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": 5,
    "funded_day": 11,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Care Capital",
         "permalink": "care-capital",
         "image":
          {"available_sizes":
            [[[110,
               80],
              "assets/images/resized/0004/9581/49581v1-max-150x150.jpg"],
             [[110,
               80],
              "assets/images/resized/0004/9581/49581v1-max-250x250.jpg"],
             [[110,
               80],
              "assets/images/resized/0004/9581/49581v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Venrock",
         "permalink": "venrock",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0001/6279/16279v1-max-150x150.jpg"],
             [[250,
               87],
              "assets/images/resized/0001/6279/16279v1-max-250x250.jpg"],
             [[351,
               123],
              "assets/images/resized/0001/6279/16279v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Red Abbey Venture Partners",
         "permalink": "red-abbey-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               98],
              "assets/images/resized/0004/6604/46604v1-max-150x150.jpg"],
             [[175,
               115],
              "assets/images/resized/0004/6604/46604v1-max-250x250.jpg"],
             [[175,
               115],
              "assets/images/resized/0004/6604/46604v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Aberdare Ventures",
         "permalink": "aberdare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               28],
              "assets/images/resized/0005/3038/53038v1-max-150x150.jpg"],
             [[250,
               47],
              "assets/images/resized/0005/3038/53038v1-max-250x250.jpg"],
             [[300,
               57],
              "assets/images/resized/0005/3038/53038v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Rho Capital Partners",
         "permalink": "rho-capital-ventures",
         "image":
          {"available_sizes":
            [[[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-150x150.jpg"],
             [[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-250x250.jpg"],
             [[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/anacor-gets-15m-gsk/2010-07-30?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Anacor gets $15M from GSK",
    "raised_amount": 15000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 7,
    "funded_day": 30,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "GSK Venture Fund",
         "permalink": "gsk-venture-fund",
         "image": null},
       "person": null}]},
   {"round_code": "grant",
    "source_url": "http://www.finsmes.com/2010/11/anacor-pharmaceuticals-receives-15m-us.html",
    "source_description": "Anacor Pharmaceuticals Receives $1.5M US Treasury Grant",
    "raised_amount": 1500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 11,
    "funded_day": 4,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "United States Department of the Treasury",
         "permalink": "united-states-department-of-the-treasury",
         "image":
          {"available_sizes":
            [[[150,
               18],
              "assets/images/resized/0027/0094/270094v1-max-150x150.png"],
             [[250,
               30],
              "assets/images/resized/0027/0094/270094v1-max-250x250.png"],
             [[385,
               47],
              "assets/images/resized/0027/0094/270094v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "private_equity",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1411158/000141115813000002/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 5000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 4,
    "funded_day": 9,
    "investments":
     []},
   {"round_code": "debt_round",
    "source_url": "http://www.pehub.com/2013/06/12/anacor-receives-45-mln-loan-hercules-technology-growth-capital/?utm_source=dlvr.it\u0026utm_medium=twitter",
    "source_description": "Anacor Receives $45 Mln Loan from Hercules Technology Growth Capital",
    "raised_amount": 45000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 6,
    "funded_day": 12,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Hercules Technology Growth Capital",
         "permalink": "hercules-technology-growth",
         "image":
          {"available_sizes":
            [[[150,
               51],
              "assets/images/resized/0001/4495/14495v6-max-150x150.png"],
             [[250,
               86],
              "assets/images/resized/0001/4495/14495v6-max-250x250.png"],
             [[416,
               144],
              "assets/images/resized/0001/4495/14495v6-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "1020 East Meadow Circle",
    "address2": "",
    "zip_code": "94303-4230",
    "city": "Palo Alto",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.431409,
    "longitude": -122.10649}],
 "milestones":
  [{"description": "Anacor Pharmaceuticals Re-Files IPO To Fuel Phase III Trials",
    "stoned_year": 2010,
    "stoned_month": 9,
    "stoned_day": 13,
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32\u0026aid=DJFVW00020100910e69d000xd\u0026r=Rss\u0026s=DJFVW",
    "source_text": "",
    "source_description": "Anacor Pharmaceuticals Re-Files IPO To Fuel Phase III Trials",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Anacor Pharmaceutical",
      "permalink": "anacor-pharmaceutical"}},
   {"description": "Anacor Prices Scaled-Back 12M-Share IPO At $5 Each ",
    "stoned_year": 2010,
    "stoned_month": 11,
    "stoned_day": 24,
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29\u0026aid=DJFVLS0020101124e6bo00002\u0026r=Rss\u0026s=DJFVLS",
    "source_text": "",
    "source_description": "Anacor Prices Scaled-Back 12M-Share IPO At $5 Each ",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Anacor Pharmaceutical",
      "permalink": "anacor-pharmaceutical"}},
   {"description": "Anacor inks $160M acne drug pact with Medicis\r\n\r\n",
    "stoned_year": 2011,
    "stoned_month": 2,
    "stoned_day": 10,
    "source_url": "http://www.fiercebiotech.com/story/anacor-inks-160m-acne-drug-pact-medicis/2011-02-10?utm_medium=rss\u0026utm_source=rss",
    "source_text": "",
    "source_description": "Anacor inks $160M acne drug pact with Medicis",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Anacor Pharmaceutical",
      "permalink": "anacor-pharmaceutical"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        142],
       "assets/images/resized/0004/9568/49568v1-max-150x150.jpg"],
      [[250,
        237],
       "assets/images/resized/0004/9568/49568v1-max-250x250.jpg"],
      [[450,
        427],
       "assets/images/resized/0004/9568/49568v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}